Intrinsic Value of S&P & Nasdaq Contact Us

Boston Therapeutics, Inc. BTHE OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score
5/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Boston Therapeutics, Inc. (BTHE) has 9 known insider and institutional holders on record. The largest holder is PLATT DAVID with 7,560,985 shares. Other notable holders include Cheng Conroy Chi-Heng and RAUSCH CARL W.

BTHE Insider Ownership

Top Holder
PLATT DAVID
7,560,985 shares
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Platt David 10 Percent Owner, Officer: CEO and Chairman 7,560,985 2015-05-18
100%
2 Cheng Conroy Chi-heng Director 1,799,800 2014-04-30
24%
3 Rausch Carl W Chief Executive Officer 1,000,000 2018-02-13
13%
4 Rome Jonathan B Other: (2) 625,000 2014-01-29
8%
5 Esber Henry Jemil Director 228,000 2015-03-20
3%
6 Squeglia Anthony Don Chief Financial Officer 128,350 2015-03-11
2%
7 Eliaz Rom E Director 20,000 2014-04-04
0%
8 Conaway Dale H Director 7,100 2015-06-08
0%
9 Neill Sydney Colin Director 100 2014-04-04
0%

No ownership data available for BTHE.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message